Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Quik

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1990
Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junctionM Quik, B Collier, T Audhya, et al.
Brain Research|August 11, 1978
Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injectionK P Minneman, M Quik, P C Emson
Journal of Neurochemistry|January 15, 2004
Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatumM Quik, T Bordia, L Forno, et al.
Neuroscience|January 1, 1990
Phorbol esters and d-tubocurarine up-regulate alpha-bungarotoxin sites in chromaffin cells in culture via distinct mechanismsS Geertsen, R Afar, J M Trifaró, et al.
Molecular Pharmacology|October 1, 1988
Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMPS Geertsen, R Afar, J M Trifaró, et al.
Neuroscience|January 1, 1992
Thymopoietin, a polypeptide ligand for the alpha-bungarotoxin binding site in brain: an autoradiographic studyR Afar, P B Clarke, G Goldstein, et al.
Molecular Pharmacology|March 1, 1991
Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell culturesM Quik, H el-Bizri, T Audhya, et al.
British Journal of Pharmacology|June 1, 1981
Convulsant and possible anticholinergic actions of dendrotoxin in the amphibian spinal cordB Collier, A L Padjen, M Quik, et al.
Journal of the Neurological Sciences|November 1, 1979
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's diseaseM Quik, E G Spokes, A V Mackay, et al.
Neuroscience|June 21, 2002
Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damageM Quik, Y Polonskaya, J M McIntosh, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1990
Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junctionM Quik, B Collier, T Audhya, et al.
Brain Research|August 11, 1978
Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injectionK P Minneman, M Quik, P C Emson
Journal of Neurochemistry|January 15, 2004
Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatumM Quik, T Bordia, L Forno, et al.
Neuroscience|January 1, 1990
Phorbol esters and d-tubocurarine up-regulate alpha-bungarotoxin sites in chromaffin cells in culture via distinct mechanismsS Geertsen, R Afar, J M Trifaró, et al.
Molecular Pharmacology|October 1, 1988
Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMPS Geertsen, R Afar, J M Trifaró, et al.
Neuroscience|January 1, 1992
Thymopoietin, a polypeptide ligand for the alpha-bungarotoxin binding site in brain: an autoradiographic studyR Afar, P B Clarke, G Goldstein, et al.
Molecular Pharmacology|March 1, 1991
Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell culturesM Quik, H el-Bizri, T Audhya, et al.
British Journal of Pharmacology|June 1, 1981
Convulsant and possible anticholinergic actions of dendrotoxin in the amphibian spinal cordB Collier, A L Padjen, M Quik, et al.
Journal of the Neurological Sciences|November 1, 1979
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's diseaseM Quik, E G Spokes, A V Mackay, et al.
Neuroscience|June 21, 2002
Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damageM Quik, Y Polonskaya, J M McIntosh, et al.
Pageof 10